Connect Sign In
The Association for the Advancement of Blood and Biotherapies recommends that providers use a restrictive transfusion strategy to reduce unnecessary transfusions and the risk of adverse events.
The newest edition highlights innovations that keep ARUP at the forefront of toxicology testing. Also featured: ARUP’s expanded capacity for cytogenetics testing.
A platform clients use to reduce testing waste, lower cost per test, and improve patient safety has won the prestigious Choosing Wisely Champion Award from the American Society for Clinical Pathology.
New ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ will improve patient lives by advancing groundbreaking diagnostic and prognostic technologies.
A novel event organized by ARUP’s Patent Committee aimed to highlight creative solutions that may not lead to patents but still advance laboratory medicine and improve patient care.
ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay, AAV5 DetectCDx™, which helps determine patient eligibility for a new gene therapy for severe hemophilia A.
ARUP’s Clinical Trials and PharmaDx groups supported Blueprint Medicines’ clinical trials that led to FDA approval for AYVAKIT® (avapritinib), a new treatment for indolent systemic mastocytosis.
ARUP and Gestalt Diagnostics announced a partnership under which ARUP will adopt Gestalt’s PathFlow® platform as a foundation for future digital pathology initiatives.
ARUP researchers coauthored more than 160 peer-reviewed articles on groundbreaking research in 2022. Their insights and innovation helped advance laboratory medicine for improved patient outcomes.
The Spring 2023 edition of Magnify: The Art and Science of Diagnostic Medicine, is now available online and explores the legacy and future of transfusion medicine at ARUP.
Drawing on ARUP experts' extensive knowledge about the diagnosis and treatment of cerebral creatine deficiency syndromes, a new initiative seeks answers for those with creatine transporter deficiency.
Rong Mao, MD, FACMG, looks forward to bridging the gap between laboratory and clinical practice after her recent election to the ACMGF board of directors, and will present at the ACMG meeting.
